 Presently there is also a phase I study ongoing that investigates the combination of afatinib with gemcitabine ClinicalTrials.gov Identifier: NCT01251653 U10-2249-02 . Possibly the data will be available once the study is ready to start. Otherwise a modification of the regimen will be planned once the respective data will be available. 